Home > News Shots > India

By Nidharshana | Jun 19, 2020 10:47 AM

The only anti-viral drug that can potentially treat the coronavirus, with emergency use authorisation, Remdesivir, will be available in the Indian market by the end of this month.

COVID Cure India to Receive New drug Remdesivir Soon

The Drug Controller General of India has recently approved Remdesivir to be used on severely ill and hospitalised coronavirus patients. It is soon to be domestically manufactured to ensure wide availability.

The drug as an injection is not recommended to those with severe renal problems, pregnant women, lactating women, and for children below the age of 12. However, each dosage of the medicine costs Rs.5,000. An injection costs the same. A patient who begins the course will have to take 11 dosages which takes the total amount to Rs.55,000.

“India is a fairly efficient market in terms of competition. Price will be a dynamic thing depending on demand and supply, but it will not be a bottleneck for patients. Today a patient is paying anything between Rs.35,000 and Rs.60,000 a day in hospitals. This drug reduces at least three to four days of one’s hospital stay. In that way, the drug will pay for itself,” said a licensee.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      



This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. COVID Cure India to Receive New drug Remdesivir Soon | India News.